Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://abelukzx435817.blogspothub.com/37861034/trelaglutide-exploring-a-new-option-for-chronic-diseases